Aardvark Therapeutics AARD Ratios (2024-2026)

NASDAQ AARD
$6.35 +0.46 (+7.81%)
As of: Aug 21, 2026 · 11:09 AM EDT
Ratios Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Efficiency
Assets Average (Quarter) 117.27M152.25M140.35M125.20M107.89M90.03M
Leverage & Solvency
Interest Coverage Ratio (Quarter) -2.98-0.01M-990.50
Times Interest Earned (Quarter) -2.98-0.01M-990.50
Valuation
Enterprise Value (Quarter) -73.66M-276.06M-257.62M-213.47M-110.03M-119.96M-73.92M
Return Ratios
Return on Capital Employed (Quarter) -27.93%-28.79%-41.25%-54.71%-77.60%-88.42%
Return on Assets (Quarter) 0.00%0.00%0.00%0.00%-0.01%-0.01%